Full-Time

Infusion Clinic Medical Assistant

Murray

Posted on 11/30/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$16.33 - $23.97/hr

Murray, UT, USA

In Person

Willing to cross-cover at surrounding clinics (Tooele, American Fork, Layton, Murray) as needed.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Certification as a Medical Assistant from a designated medical assistant program OR 2 years of relative working experience as a certified medical assistant, or in a specialty field where job responsibilities or basic qualifications have been utilized.
  • Must be able to draw blood
  • Must be able to administer biologic injections
  • Must be able to start IVs
  • Demonstrates competency in patient care standards required for safe delivery of services as evidenced by completion of orientation and appropriate competencies
  • Basic level computer skills (for example: start up and shut down computer, use mouse to point and click, start and close programs, switch between programs, save files, print documents, access information on-line etc.)
  • Experience establishing and maintaining relationships with individuals at all levels of the organization
Responsibilities
  • IV placement for infusions, administer injections, obtain blood specimens by performing venipuncture, maintain specimen integrity, maintain quality results by following practice procedures, room patients, obtain vitals, keep infusion rooms clean and follow compliance, account for medical supply stock, patient education, port access, completion and passing score of annual skills day
  • Patient follow up including but not limited to: contact patients in follow-up after their treatments to be sure they are not having adverse reactions, answer routine questions from patients and family, assist clinical team
  • Members (APPs and RN’s), help take clinically oriented phone calls from patients, report to supervisor the need for any supplies
  • Uphold the standard of handling PHI while using this information to prepare for the patients visit and to keep a safe and smooth flow within the clinic. Applying the minimum necessary standard of HIPPA.
  • Maintain a safe, secure and healthy work environment by following standards and procedures and complying with legal regulations
  • Take and distribute messages, coordinate appointments if needed, help schedule, and other EMR tasks
  • Contribute to the team by performing and accomplishing related results as needed, retrieve information when needed, keep open communication with supervisor that is clear and effective
  • Continue advancing job knowledge by participating in any offered in-services, trainings, educational opportunities and maintaining personal and professional networks
  • Assist with faxing, printing, phone calls to referring providers, upholding continuity of care, copay assistant programs, free medication programs, and appropriate documentation following verbal or written correspondence
  • Participate in on-the-job training to obtain IV placement, phlebotomy, and port certifications if those have not yet been acquired
Desired Qualifications
  • IV Certified
  • Phlebotomy certified
  • Certified Medical Assistant

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE